Literature DB >> 30867141

NLRC5: A paradigm for NLRs in immunological and inflammatory reaction.

Yuting Wu1, Tianlu Shi2, Jun Li3.   

Abstract

The nucleotide-binding domain leucine-rich repeat containing (NLR) family of proteins is mainly involved in microbial pathogen recognition, inflammatory responses, and cell death. NLRC5, the largest member of the NLR family, is currently receiving an increasing level of attention. NLRC5 has been demonstrated to be a potent negative regulator of NF-κB signaling pathway-mediated inflammatory response. Moreover, accumulating evidence has indicated that NLRC5 is closely related to pathological processes of various cancers. In this review, we present an overview on NLRC5, addressing its underlying molecular mechanisms and implications in host defense, inflammatory response, and associated cancers.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cancers; Host defense; Inflammatory response; NLRC5; NLRS

Mesh:

Substances:

Year:  2019        PMID: 30867141     DOI: 10.1016/j.canlet.2019.03.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?

Authors:  Shahram Torkamandi; Shima Bahrami; Tahereh Ghorashi; Mohammad Dehani; Hadi Bayat; Seyyed Mohamad Hoseini; Somaye Rezaei; Mohsen Soosanabadi
Journal:  Genes Immun       Date:  2021-11-15       Impact factor: 2.676

2.  Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells.

Authors:  Ming-Zhen Zhao; Yu Sun; Xiao-Feng Jiang; Li Liu; Li Liu; Li-Xin Sun
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

3.  NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.

Authors:  Yijun Fan; Zhen Dong; Yuchuan Shi; Shiying Sun; Bing Wei; Lei Zhan
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

4.  NLRC5 attenuates inflammatory response in IL-1β-stimulated human osteoarthritis chondrocytes through the NF-κB signaling pathway.

Authors:  Yiping Mu; Yang Zhang; Jie Wu; Qi Li
Journal:  Aging (Albany NY)       Date:  2021-08-26       Impact factor: 5.682

5.  NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression.

Authors:  Su-Ding Zhu; Jing Zhang; Xiao-Jing Liu; Jun-Hui Zhang; Bing Wei; Wen-Yan Wang; Yi-Jun Fan; Dan Li; Yun-Xia Cao; Lei Zhan
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic β cells.

Authors:  Florian Szymczak; Maria Inês Alvelos; Sandra Marín-Cañas; Ângela Castela; Stéphane Demine; Maikel Luis Colli; Anne Op de Beeck; Sofia Thomaidou; Lorella Marselli; Arnaud Zaldumbide; Piero Marchetti; Décio L Eizirik
Journal:  Sci Adv       Date:  2022-09-14       Impact factor: 14.957

Review 7.  NLRC5: A Potential Target for Central Nervous System Disorders.

Authors:  Lu Zhang; Cui Jiao; Lingjuan Liu; Aiping Wang; Li Tang; Yi Ren; Peng Huang; Jie Xu; Dingan Mao; Liqun Liu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

Review 8.  Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration.

Authors:  Alessandra Tammaro; Jesper Kers; Angelique M L Scantlebery; Sandrine Florquin
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.